NCT04478344

Brief Summary

Low back pain (LBP) is a common complaint in the clinical setting. Among all the differential diagnosis for LBP, superior cluneal nerve (SCN) entrapment is the commonly omitted one. The superior cluneal nerve is the terminal branch of the lateral branches of the posterior rami of the L1-L3 spinal nerves, which passes through the osseous tunnel interposed between the thoracolumbar fascia and iliac crest. This nerve can be entrapped due to poor posture, trauma or stretching of the surrounding thoracolumbar fascia and osseous membrane. The cardinal symptom of the superior cluneal nerve entrapment is buttock pain. Sometimes the pain may radiate to the lower limb, which mimics sciatica, and makes the diagnosis difficult. Early diagnosis and treatment of SCN entrapment is crucial, which can facilitate the improvement of health related quality of life and decrement the socioeconomic loss due to disability. The study aims is (1) to scan the SCN and thoracolumbar fascia by ultrasound in patients with LBP and normal subjects. The transcutaneous electrical stimulation will be used to confirm the location of SCN by asking the subject to depict the sensory distribution after stimulation; (2) to analyze the related factors of LBP with SCN entrapment, which may help in setting up the diagnostic criteria of SCN entrapment; (3) to analyze the therapeutic effect of perineural injection to SCN in SCN entrapment, and to find the factors that related responsiveness.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 20, 2020

Completed
4 months until next milestone

Study Start

First participant enrolled

November 27, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
Last Updated

June 28, 2023

Status Verified

December 1, 2022

Enrollment Period

2.5 years

First QC Date

July 9, 2020

Last Update Submit

June 25, 2023

Conditions

Keywords

UltrasonographySuperior cluneal nerveNerve entrapmentPredictionUltrasound-guided injectionHydrodissection

Outcome Measures

Primary Outcomes (3)

  • Oswestry Disability Questionnaire

    Oswestry Disability Questionnaire, A 10 item questionnaire, score ranges from 0 to 100, and a higher score indicates worse function.

    Change of the score between one month and baseline, and change of the score between three months and baseline

  • Short Form-36 Questionnaire

    Reflect 8 domains of health, including physical functioning, physical role, pain, general health, vitality, social func-tion, emotional role, and mental health. The categories of physical role and emotional role reflect performance at the activity and participation levels. The score will be transformed between 0 to 100. The higher score means better health condition in each domain.

    Change of the score between one month and baseline, and change of the score between three month and baseline

  • Visual analogue scale

    The pain scale to evaluate pain, from 0 to 10. The lower means less pain.

    Change of the score between one month and baseline, and change of the score between three months and baseline

Secondary Outcomes (1)

  • Ultrasound evaluation of SCN (Grey scale)

    Measurement change between one month and baseline and between three months and baseline

Study Arms (2)

Ultrasound guided hydrodissection to superior cluneal nerve

EXPERIMENTAL

Patients with superior cluneal nerve enttrappment given by ultrasound guided perineural injection with a mixture of 1 mL of 50% dextrose, 4 mL of 1% lidocaine, and 5 mL of 0.9% normal saline to superior cluneal nerve of affected side.

Other: Ultrasound guided hydrodissection of superior cluneal nerve

Control arm

NO INTERVENTION

Patients without superior cluneal nerve entrappment

Interventions

Intervention procedure: hydrodissection to the superior cluneal nerve entrapment; Device for guidance of injection: high-resolution ultrasound ; Drug for injection: a mixture of 1 mL of 50% dextrose, 4 mL of 1% lidocaine, and 5 mL of 0.9% normal saline

Ultrasound guided hydrodissection to superior cluneal nerve

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • non-mechanical low back pain
  • referred low back pain (tumor, infection, inflammatory arthritis, Scheuermann disease,Paget disease, herpetic neuralgia)
  • trauma
  • acute compression fracture
  • acute herniated disc
  • underwent lumbar region nerve block within 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital, Bei-Hu Branch

Taipei, Wanhua District, 108, Taiwan

RECRUITING

Related Publications (1)

  • Wu WT, Mezian K, Nanka O, Chen LR, Ricci V, Lin CP, Chang KV, Ozcakar L. Enhancing diagnosis and treatment of superior cluneal nerve entrapment: cadaveric, clinical, and ultrasonographic insights. Insights Imaging. 2023 Jul 3;14(1):116. doi: 10.1186/s13244-023-01463-0.

MeSH Terms

Conditions

Low Back PainCharcot-Marie-Tooth DiseaseNerve Compression Syndromes

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsHereditary Sensory and Motor NeuropathyNervous System MalformationsNervous System DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesPolyneuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Study Officials

  • Ke-Vin Chang, MD,PhD

    National Taiwan University Hospital Bei-Hu Branch

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ke-Vin Chang, MD,PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 9, 2020

First Posted

July 20, 2020

Study Start

November 27, 2020

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

June 28, 2023

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations